跳转至内容
Merck
CN

MAB348

Anti-Beta (β)-Amyloid antibody

CHEMICON®, mouse monoclonal, 22C11

别名:

抗APP A4, 抗淀粉样前体蛋白A4

登录 查看组织和合同定价。

选择尺寸

关于此项目

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗APP A4抗体，a.a.APP{NT}的66-81，克隆22C11, clone 22C11, Chemicon®, from mouse

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

22C11, monoclonal

species reactivity

rat, fish, human, mouse, canine, pig, monkey

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

isotype

IgG1

NCBI accession no.

NM_000484.2
NM_201413.1
NM_201414.1

UniProt accession no.

P05067

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... APP(351)

相关类别

Analysis Note

对照
脑组织，脑细胞裂解物

Application

抗APP A4抗体，a.a.66-81 of APP，克隆22C11已用于免疫组织化学和免疫印迹（1:1000）。

Biochem/physiol Actions

β/A4淀粉样前体蛋白（APP）可发生蛋白水解裂解，并产生β/A4肽。在脑皮层实质和脑膜血管中观察到这种肽的细胞外沉积物，这标志着阿尔茨海默病的病理状态。′APP基因突变可导致早发性阿尔茨海默病和遗传性脑出血伴淀粉样变。′
抗APP A4抗体与pre-A4反应，并识别pre-A4分子N-末端氨基酸66-81（Hilbich 等，1993）。 22C11识别APP的全部三种亚型，未成熟~110kDa，sAPP~120kDa，成熟~130kDa（Hoffmann et al.，2000）。抗APP A4抗体可与APLP2发生交叉反应（Slunt，1994）。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

β/A4淀粉样前体蛋白（APP）是一种跨膜糖蛋白，存在三种亚型。这种蛋白由一个单通路跨膜结构域、一个大的细胞外N末端结构域和一个短的细胞质C末端尾部组成。APP基因位于人染色体21q21.3-q22。
110/120/130 kDa

Immunogen

纯化的重组阿尔茨海默病前体A4（pre A4695）融合蛋白。
表位：APP{N-末端}的a.a.66-81

Other Notes

浓度：请参考批次特异性浓缩物的分析证书。

Physical form

形式：纯化
纯化的蛋白 A
蛋白 A 纯化的小鼠免疫球蛋白，溶于 20 mM 磷酸钠，250 mM NaCl，pH.7.6 和 0.1％ 叠氮化钠中作为防腐剂的溶液。

Preparation Note

自发运之日起，在 2–8°C 条件下可稳定保存 1 年避免反复冻融。为了最大程度地回收产品，在融化后和取下盖子之前，将原始样品瓶进行离心。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品？  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_c

Not applicable

法规信息

常规特殊物品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein
Caporaso G L, et al.
Proceedings of the National Academy of Sciences of the USA, 89(7), 3055-3059 (1992)
Predicting memapsin 2 (?-secretase) hydrolytic activity.
Li, X; Bo, H; Zhang, XC; Hartsuck, JA; Tang, J
Protein Science null
Response of Circulating Inflammatory Markers to Intermittent Hypoxia-Hyperoxia Training in Healthy Elderly People and Patients with Mild Cognitive Impairment
Serebrovska Z O, et al.
All Life, 12(3), 432-432 (2022)
G L Caporaso et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 14(5 Pt 2), 3122-3138 (1994-05-01)
Abnormal metabolic processing of the beta/A4 amyloid precursor protein (APP) has been implicated in the pathogenesis of Alzheimer disease. Several aspects of normal APP processing have been elucidated, but the precise cellular trafficking of APP remains unclear. To investigate APP
Robert Tamayev et al.
The EMBO journal, 30(12), 2501-2509 (2011-05-19)
An autosomal dominant mutation in the BRI2/ITM2B gene causes familial Danish dementia (FDD). Analysis of FDD(KI) mice, a mouse model of FDD genetically congruous to the human disease since they carry one mutant and one wild-type Bri2/Itm2b allele, has shown
查看所有相关文献

实验方案

Alzheimer’s In A Dish™: 3D Neural Stem Cell Models of Alzheimer's Disease

A stem cell culture protocol to generate 3D NSC models of Alzheimer’s disease using ReNcell human neural stem cell lines.

相关内容

Research Focus - Volume 2, 2013

Alzheimer’s Disease: Amyloid Cascade and Beyond Product Focus

SNAP i.d. 2.0 System Brochure

There’s so much room for experimental variability in traditional immunodetection workflows. For your peace of mind – and ours – we designed the SNAP i.d.® 2.0 system to streamline your Western blot and immunohistochemistry experiments. The concept is simple: a vacuum-driven flow of blocking, antibody, and washing solutions reduces slide and membrane handling. That means a lot less shaking, dipping, pouring and waiting. And now you can process multiple blots and slides in parallel, so it’s easy to apply consistent conditions across experiments.

PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持